Viz Sees $7.5M In Seed Funding To Apply AI To Stroke Diagnosis
San Francisco-based Viz, a developer of artificial intelligence software to help in emergency treatment of stroke, has raised $7.5M in a seed funding. The funding was led by DHVC (Danhua Capital) and Eric Schmidt's Innovation Endeavors and also included Jerry Yang's AME Cloud Ventures. The company said it is developing artificial intelligence software which uses medical imaging to better treat stroke patients. The company's founders are Chris Mansi (neurosurgeon and Stanford MBA); David Golan, Ph.D. (Stanford postdoc); and Manoj Ramachandran (orthopedic surgeon).
posted on Friday, May 26, 2017 (Link to more information)
Related companies:
VIZ.AI, INC.
Related stories:
> Jan Medical Raises $7.5M For Concussion, Stroke Diagnostics
> Velomedix Finds $10.2M For Treating Heart Attacks, Stroke
> DabKick Sees $750K In Seed Funding For Social VR Software
> Ringadoc Calls Up $750K
> Qool Therapeutics Gets $8M
silicontap.com Home